Brimonidine Tartrate Solution
Product Images NDC 61314-144

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Brimonidine Tartrate (NDC 61314-144). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sandoz Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

0.15percent5mlcarton

Packaging label for Brimonidine Tartrate Ophthalmic Solution 0.15%, a sterile eye drop solution in a 5 mL bottle. Labeled for topical ophthalmic use only, Rx only. Manufactured by Alcon Laboratories for Sandoz Inc. Includes NDC 61314-144-05 and storage instructions. Label also lists inactive ingredients and dosage directions.*

FDA Label Image

Chemicalstructure

Chemical structure of Brimonidine Tartrate, showing the molecular arrangement of its atoms including a bromine-substituted bicyclic ring and the tartrate moiety, as depicted in the diagram.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.